PPCB · Company research
Propanc Biopharma, Inc. (PPCB): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) Stock Price, News, Quote & History - Yahoo! Finance Canada | Propanc Biopharma, Inc. (PPCB) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 17, 2026 | neutral | 0 | 0.6 |
| Propanc Biopharma, Inc. (PPCB) stock price, news, quote and history - Yahoo Finance Australia | Propanc Biopharma, Inc. (PPCB) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 16, 2026 | neutral | 0 | 0.6 |
| Resistant pancreatic cancer cells invaded 80% less with a two-treatment combination in lab tests. - Stock Titan | Resistant pancreatic cancer cells invaded 80% less with a two-treatment combination in lab tests. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| In a 46-patient advanced-cancer program, 19 lived beyond predicted life expectancy. - Stock Titan | In a 46-patient advanced-cancer program, 19 lived beyond predicted life expectancy. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| PPCB Stock Jumps As Propanc Biopharma Accelerates PRP Cancer Program - Timothy Sykes | PPCB Stock Jumps As Propanc Biopharma Accelerates PRP Cancer Program Timothy Sykes | View source ↗ | Timothy Sykes | Aug 27, 2026 | neutral | 0 | 0.6 |
| Propanc’s pancreatic cancer candidate extends animal survival more than 2.5-fold - Stock Titan | Propanc’s pancreatic cancer candidate extends animal survival more than 2.5-fold Stock Titan | View source ↗ | Stock Titan | Aug 27, 2026 | neutral | 0 | 0.6 |
| PPCB Stock Pops As Propanc Biopharma Advances PRP Cancer Program - StocksToTrade | PPCB Stock Pops As Propanc Biopharma Advances PRP Cancer Program StocksToTrade | View source ↗ | StocksToTrade | Aug 27, 2026 | neutral | 0 | 0.6 |
| Propanc Biopharma Surges After New Pancreatic Cancer Data - Quiver Quantitative | Propanc Biopharma Surges After New Pancreatic Cancer Data Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 27, 2026 | neutral | 0 | 0.6 |
| Revolution Medicines’ Pancreatic Cancer Drug Approval Validates Microcap Propanc Biopharma’s Breakthrough - Benzinga | Revolution Medicines’ Pancreatic Cancer Drug Approval Validates Microcap Propanc Biopharma’s Breakthrough Benzinga | View source ↗ | Benzinga | Aug 27, 2026 | neutral | 0 | 0.6 |
| PPCB Stock Surges Over 200% Just Days After Implementing Reverse Share Split – What’s Driving Today’s Smashing Rally? - Yahoo Finance | PPCB Stock Surges Over 200% Just Days After Implementing Reverse Share Split – What’s Driving Today’s Smashing Rally? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 11, 2026 | neutral | 0 | 0.6 |
| Cancer-drug developer Propanc sets aside $5M to buy its own stock - Stock Titan | Cancer-drug developer Propanc sets aside $5M to buy its own stock Stock Titan | View source ↗ | Stock Titan | Jun 11, 2026 | neutral | 0 | 0.6 |
| PPCB Stock Pops As Propanc Biopharma Advances PRP Trials - Timothy Sykes | PPCB Stock Pops As Propanc Biopharma Advances PRP Trials Timothy Sykes | View source ↗ | Timothy Sykes | Jun 11, 2026 | neutral | 0 | 0.6 |
| PPCB Stock Explodes As PRP Trial Plans Heat Up - StocksToTrade | PPCB Stock Explodes As PRP Trial Plans Heat Up StocksToTrade | View source ↗ | StocksToTrade | Jun 11, 2026 | neutral | 0 | 0.6 |
| Propanc Biopharma, Inc. Announces 1-for-25 Reverse Stock Split to Enhance Nasdaq Compliance | PPCB Stock News - Quiver Quantitative | Propanc Biopharma, Inc. Announces 1-for-25 Reverse Stock Split to Enhance Nasdaq Compliance | PPCB Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | May 14, 2026 | neutral | 0 | 0.6 |
| PPCB Should I Buy - Intellectia AI | PPCB Should I Buy Intellectia AI | View source ↗ | Intellectia AI | Feb 16, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Aug 17, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.